_version_ 1783298530506440704
author Tang, Y-T
Wang, D
Luo, H
Xiao, M
Zhou, H-S
Liu, D
Ling, S-P
Wang, N
Hu, X-L
Luo, Y
Mao, X
Ao, Q-L
Huang, J
Zhang, W
Sheng, L-S
Zhu, L-J
Shang, Z
Gao, L-L
Zhang, P-L
Zhou, M
Zhou, K-G
Qiu, L-G
Liu, Q-F
Zhang, H-Y
Li, J-Y
Jin, J
Fu, L
Zhao, W-L
Chen, J-P
Du, X
Huang, G
Wang, Q-F
Zhou, J-F
Huang, L
author_facet Tang, Y-T
Wang, D
Luo, H
Xiao, M
Zhou, H-S
Liu, D
Ling, S-P
Wang, N
Hu, X-L
Luo, Y
Mao, X
Ao, Q-L
Huang, J
Zhang, W
Sheng, L-S
Zhu, L-J
Shang, Z
Gao, L-L
Zhang, P-L
Zhou, M
Zhou, K-G
Qiu, L-G
Liu, Q-F
Zhang, H-Y
Li, J-Y
Jin, J
Fu, L
Zhao, W-L
Chen, J-P
Du, X
Huang, G
Wang, Q-F
Zhou, J-F
Huang, L
author_sort Tang, Y-T
collection PubMed
description
format Online
Article
Text
id pubmed-5802497
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58024972018-02-08 Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes Tang, Y-T Wang, D Luo, H Xiao, M Zhou, H-S Liu, D Ling, S-P Wang, N Hu, X-L Luo, Y Mao, X Ao, Q-L Huang, J Zhang, W Sheng, L-S Zhu, L-J Shang, Z Gao, L-L Zhang, P-L Zhou, M Zhou, K-G Qiu, L-G Liu, Q-F Zhang, H-Y Li, J-Y Jin, J Fu, L Zhao, W-L Chen, J-P Du, X Huang, G Wang, Q-F Zhou, J-F Huang, L Blood Cancer J Correspondence Nature Publishing Group UK 2017-12-21 /pmc/articles/PMC5802497/ /pubmed/29263371 http://dx.doi.org/10.1038/s41408-017-0021-z Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Tang, Y-T
Wang, D
Luo, H
Xiao, M
Zhou, H-S
Liu, D
Ling, S-P
Wang, N
Hu, X-L
Luo, Y
Mao, X
Ao, Q-L
Huang, J
Zhang, W
Sheng, L-S
Zhu, L-J
Shang, Z
Gao, L-L
Zhang, P-L
Zhou, M
Zhou, K-G
Qiu, L-G
Liu, Q-F
Zhang, H-Y
Li, J-Y
Jin, J
Fu, L
Zhao, W-L
Chen, J-P
Du, X
Huang, G
Wang, Q-F
Zhou, J-F
Huang, L
Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
title Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
title_full Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
title_fullStr Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
title_full_unstemmed Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
title_short Aggressive NK-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
title_sort aggressive nk-cell leukemia: clinical subtypes, molecular features, and treatment outcomes
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802497/
https://www.ncbi.nlm.nih.gov/pubmed/29263371
http://dx.doi.org/10.1038/s41408-017-0021-z
work_keys_str_mv AT tangyt aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT wangd aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT luoh aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT xiaom aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT zhouhs aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT liud aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT lingsp aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT wangn aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT huxl aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT luoy aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT maox aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT aoql aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT huangj aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT zhangw aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT shengls aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT zhulj aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT shangz aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT gaoll aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT zhangpl aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT zhoum aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT zhoukg aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT qiulg aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT liuqf aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT zhanghy aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT lijy aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT jinj aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT ful aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT zhaowl aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT chenjp aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT dux aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT huangg aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT wangqf aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT zhoujf aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes
AT huangl aggressivenkcellleukemiaclinicalsubtypesmolecularfeaturesandtreatmentoutcomes